{"entity":{"type":"insider","cik":"0001284500","url":"/insider/0001284500","json_url":"/insider/0001284500.json","name":"TRABER PETER G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":22,"first":"2012-10-09","last":"2023-09-26","span_basis":"filed_date"},"name_variants":[{"name":"TRABER PETER G","source":"filing","n_filings":22,"first_seen":"2012-10-09","last_seen":"2023-09-26"}],"transactions":[{"id":8746034,"accession":"0001453687-23-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-23-000067","line_url":"/filing/0001453687-23-000067#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":705.0,"shares_display":"705","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":747.3,"total_display":"747.30","total_whole":"747","shares_owned_after":451826.0,"shares_owned_after_display":"451,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-26","scope":"insider"},{"id":8299734,"accession":"0001453687-23-000032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001453687-23-000032","line_url":"/filing/0001453687-23-000032","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3465.0,"shares_display":"3,465","price_per_share":1.1291966810966811,"price_display":"1.13","price_state":"stated","total_value":3912.6665,"total_display":"3,912.67","total_whole":"3,913","shares_owned_after":446141.0,"shares_owned_after_display":"446,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider","n_lines":2},{"id":8299726,"accession":"0001453687-23-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001453687-23-000032","line_url":"/filing/0001453687-23-000032","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8179.0,"shares_display":"8,179","price_per_share":1.1337152219097688,"price_display":"1.13","price_state":"stated","total_value":9272.6568,"total_display":"9,272.66","total_whole":"9,273","shares_owned_after":449601.0,"shares_owned_after_display":"449,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider","n_lines":2},{"id":6780562,"accession":"0001453687-22-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-22-000034","line_url":"/filing/0001453687-22-000034#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3226.0,"shares_display":"3,226","price_per_share":3.0859,"price_display":"3.09","price_state":"stated","total_value":9955.1134,"total_display":"9,955.11","total_whole":"9,955","shares_owned_after":251355.0,"shares_owned_after_display":"251,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4419417,"accession":"0001453687-21-000186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-21-000186","line_url":"/filing/0001453687-21-000186#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4083.0,"shares_display":"4,083","price_per_share":2.9869,"price_display":"2.99","price_state":"stated","total_value":12195.5127,"total_display":"12,195.51","total_whole":"12,196","shares_owned_after":164381.0,"shares_owned_after_display":"164,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"},{"id":4355594,"accession":"0001453687-21-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-21-000144","line_url":"/filing/0001453687-21-000144#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3636.0,"shares_display":"3,636","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":15962.04,"total_display":"15,962.04","total_whole":"15,962","shares_owned_after":154714.0,"shares_owned_after_display":"154,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-15","scope":"insider"},{"id":4260506,"accession":"0001453687-21-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-21-000078","line_url":"/filing/0001453687-21-000078#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.9925,"price_display":"3.99","price_state":"stated","total_value":79850.0,"total_display":"79,850.00","total_whole":"79,850","shares_owned_after":135500.0,"shares_owned_after_display":"135,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-27","scope":"insider"},{"id":5104334,"accession":"0001453687-21-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001453687-21-000074","line_url":"/filing/0001453687-21-000074#line-2","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.48,"price_display":"3.48","price_state":"stated","total_value":17400.0,"total_display":"17,400.00","total_whole":"17,400","shares_owned_after":115500.0,"shares_owned_after_display":"115,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-26","scope":"insider"},{"id":5104328,"accession":"0001453687-21-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-21-000074","line_url":"/filing/0001453687-21-000074#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":3.3198,"price_display":"3.32","price_state":"stated","total_value":41497.5,"total_display":"41,497.50","total_whole":"41,498","shares_owned_after":110500.0,"shares_owned_after_display":"110,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":5271836,"accession":"0001453687-21-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001453687-21-000035","line_url":"/filing/0001453687-21-000035#line-2","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":98000.0,"shares_owned_after_display":"98,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-19","scope":"insider"},{"id":5271834,"accession":"0001453687-21-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-21-000035","line_url":"/filing/0001453687-21-000035#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.5295,"price_display":"4.53","price_state":"stated","total_value":45295.0,"total_display":"45,295.00","total_whole":"45,295","shares_owned_after":88000.0,"shares_owned_after_display":"88,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-19","scope":"insider"},{"id":2609873,"accession":"0001453687-20-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-20-000133","line_url":"/filing/0001453687-20-000133#line-1","is_derivative":false,"issuer_cik":"0001284500","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001284500","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":3.2356,"price_display":"3.24","price_state":"stated","total_value":129424.0,"total_display":"129,424.00","total_whole":"129,424","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":6594252,"accession":"0001179022-18-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000054","line_url":"/filing/0001179022-18-000054#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.51,"price_display":"7.51","price_state":"stated","total_value":751000.0,"total_display":"751,000.00","total_whole":"751,000","shares_owned_after":107333.0,"shares_owned_after_display":"107,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-15","scope":"insider"},{"id":6135922,"accession":"0001179022-18-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000050","line_url":"/filing/0001179022-18-000050#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":5.8571,"price_display":"5.86","price_state":"stated","total_value":409997.0,"total_display":"409,997.00","total_whole":"409,997","shares_owned_after":107333.0,"shares_owned_after_display":"107,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":8528617,"accession":"0001179022-15-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-15-000089","line_url":"/filing/0001179022-15-000089#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":107333.0,"shares_owned_after_display":"107,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-12","scope":"insider"},{"id":8862397,"accession":"0001179022-15-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-15-000075","line_url":"/filing/0001179022-15-000075#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":10120.0,"total_display":"10,120.00","total_whole":"10,120","shares_owned_after":105333.0,"shares_owned_after_display":"105,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-01","scope":"insider"},{"id":6952477,"accession":"0000914062-14-000225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914062-14-000225","line_url":"/filing/0000914062-14-000225","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.45945,"price_display":"4.46","price_state":"stated","total_value":17837.8,"total_display":"17,837.80","total_whole":"17,838","shares_owned_after":99333.0,"shares_owned_after_display":"99,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider","n_lines":2},{"id":6984352,"accession":"0000914062-14-000222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-14-000222","line_url":"/filing/0000914062-14-000222#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.4155,"price_display":"4.42","price_state":"stated","total_value":4415.5,"total_display":"4,415.50","total_whole":"4,416","shares_owned_after":97333.0,"shares_owned_after_display":"97,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-14","scope":"insider"},{"id":5002704,"accession":"0000914062-13-000371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000371","line_url":"/filing/0000914062-13-000371#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":4450.0,"total_display":"4,450.00","total_whole":"4,450","shares_owned_after":96333.0,"shares_owned_after_display":"96,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-10","scope":"insider"},{"id":4475814,"accession":"0000914062-13-000369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000369","line_url":"/filing/0000914062-13-000369#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":95833.0,"shares_owned_after_display":"95,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-05","scope":"insider"},{"id":5314080,"accession":"0000914062-13-000328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000328","line_url":"/filing/0000914062-13-000328#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.53,"price_display":"5.53","price_state":"stated","total_value":5530.0,"total_display":"5,530.00","total_whole":"5,530","shares_owned_after":95333.0,"shares_owned_after_display":"95,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":5350243,"accession":"0000914062-13-000322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000322","line_url":"/filing/0000914062-13-000322#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.7992,"price_display":"5.80","price_state":"stated","total_value":5799.2,"total_display":"5,799.20","total_whole":"5,799","shares_owned_after":511000.0,"shares_owned_after_display":"511,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"},{"id":3429213,"accession":"0000914062-12-000274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-12-000274","line_url":"/filing/0000914062-12-000274#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.1148,"price_display":"2.11","price_state":"stated","total_value":5287.0,"total_display":"5,287.00","total_whole":"5,287","shares_owned_after":510000.0,"shares_owned_after_display":"510,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-12","filed_date":"2012-10-15","scope":"insider"},{"id":2938939,"accession":"0000914062-12-000272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-12-000272","line_url":"/filing/0000914062-12-000272#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":507500.0,"shares_owned_after_display":"507,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-09","filed_date":"2012-10-10","scope":"insider"},{"id":3459297,"accession":"0000914062-12-000270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-12-000270","line_url":"/filing/0000914062-12-000270#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001284500","owner_name":"TRABER PETER G","owner_display_name":"TRABER PETER G","owner_url":"/insider/0001284500","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":10350.0,"total_display":"10,350.00","total_whole":"10,350","shares_owned_after":505000.0,"shares_owned_after_display":"505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-08","filed_date":"2012-10-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001453687","name":"SELECTA BIOSCIENCES INC","url":"/issuer/0001453687","role":"Officer (Chief Medical Officer)","n_filings":9,"first_seen":"2020-12-16","last_seen":"2023-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director, Officer (President & CEO)","n_filings":13,"first_seen":"2012-10-09","last_seen":"2018-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001284500","retrieved_at":"2026-08-25T08:37:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}